Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain drag

The healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence will likely see broad-based growth. Specialty products and biosimilars are expected to be key growth drivers. Hospitals are projected to continue outperforming with capacity additions and improving occupancy. Margins may contract due to higher costs and new…

Why did market fall today? 7 triggers behind Rs 4 lakh crore wealth wipeout

Indian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causing major indices to fall. Oil prices surged above $92 per barrel, impacting market sentiment negatively. The Indian rupee also weakened against the US dollar amid global uncertainties. Persistent foreign investor selling further weighed on the overall market performance.

Global Market: Airbus shares surge over 5% after €5 billion buyback, ambitious 2029 profit targets

Airbus shares rose significantly after announcing a €5 billion share buyback program. The company outlined ambitious financial targets for the next five years. Airbus aims for core operating profit between €12 billion and €13 billion by 2029. Deliveries are increasing as supply chain issues gradually ease. Analysts reacted positively to the company’s improved earnings trajectory…